Allurion Technologies Inc. (ALUR)

Market Cap	86.13M
Revenue (ttm)	53.47M
Net Income (ttm)	-82.30M
Shares Out	47.85M
EPS (ttm)	-2.31
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,870
Open	1.850
Previous Close	1.910
Day's Range	1.760 - 1.900
52-Week Range	1.560 - 10.940
Beta	0.01
Analysts	Strong Buy
Price Target	5.00 (+177.78%)
Earnings Date	May 13, 2024

About ALUR

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 501
• Stock Exchange: NYSE
• Ticker Symbol: ALUR

Financial Performance

In 2023, ALUR's revenue was $53.47 million, a decrease of -16.73% compared to the previous year's $64.21 million. Losses were -$82.30 million, 102.5% more than in 2022.

Analyst Forecast

According to 2 analysts, the average rating for ALUR stock is "Strong Buy." The 12-month stock price forecast is $5.0, which is an increase of 177.78% from the latest price.

Price Target

$5.0

(177.78% upside)

Analyst Consensus: Strong Buy